Pharsight

Nucala patents expiration

List of large molecules

Patent Number Company Patent Title Patent Expiry Activity Alert
US5693323 NA Recombinant IL-5 antagonists useful in treatment of IL-5 mediated disorders
Dec, 2019

(4 years ago)

Ingredients: MEPOLIZUMAB